Myocardial Revascularization
Direct admission vs. interhospital transfer yields cost, outcomes benefits for non-STEMI
Mortality, recurrence low at 3 years in large SCAD cohort
In CABG, most outcomes similar in multiple vs. single arterial grafts
Icosapent ethyl reduces revascularization events: REDUCE-IT REVASC
Patients may not understand informed consent process before PCI
CTO PCI similar to medical therapy in CV death, MI risk at 3 years: EURO-CTO
Benefit of nonculprit PCI for STEMI consistent regardless of timing: COMPLETE
SAN FRANCISCO — In patients with STEMI and multivessel disease, a strategy of nonculprit-lesion PCI with the goal of complete revascularization was superior to culprit-only revascularization for major CV events regardless of whether complete revascularization occurred during the index procedure, days later or weeks later, according to new insights from the COMPLETE trial.
Discordant iFR, FFR results do not confer poor outcomes
SAN FRANCISCO — Among patients who had invasive coronary angiography and physiological assessments for at least one artery with intermediate coronary stenosis, having a normal fractional flow reserve value but an abnormal instantaneous wave-free ratio value or vice versa did not raise risk for poor outcomes, researchers reported.
TRANSIENT: Timing of revascularization does not impact outcomes in transient STEMI
PARIS — In patients with transient STEMI, defined as those who present with STEMI but have their ST-segment elevation and symptoms completely resolve before revascularization, immediate revascularization led to similar outcomes as delayed revascularization, according to data from the TRANSIENT trial.